Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when PIII files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Related Party (new) — Transactions with Chicago Pacific Founders, the company's largest stockholder and debtholder, required special committee approval.
P3 Health converts $252M debt to preferred stock, raises $10M to regain Nasdaq compliance
Filed April 28, 2026 · Period ending April 27, 2026 · ~1 min read
Key Changes
-
high
Converted $252.5M debt owed to largest holder Chicago Pacific Founders into three series of non-voting preferred stock with 13.5%–19.5% cumulative dividend rates to meet Nasdaq's $2.5M minimum equity requirement.
Item 5.03 — Amendments to Articles of Incorporation or Bylaws verify on EDGAR → -
high
Raised $10M initial tranche of up to $70M financing from CPF affiliates; each $1M invested includes warrants for 0.66333% of outstanding common stock, exercisable at Nasdaq Minimum Price for seven years.
Item 5.03 — Amendments to Articles of Incorporation or Bylaws verify on EDGAR → -
high
CPF gained right to designate additional independent board member and enhanced information/protective rights while maintaining 40%+ common ownership; ownership cap extended to 49.99% through Jan 2027.
Item 5.03 — Amendments to Articles of Incorporation or Bylaws verify on EDGAR → -
medium
Special committee of independent directors negotiated and approved all transactions due to related-party nature of CPF's dual role as largest stockholder and debtholder.
Item 5.03 — Amendments to Articles of Incorporation or Bylaws verify on EDGAR →
Summary
P3 Health Partners restructured its balance sheet to regain Nasdaq compliance by converting $252.5 million of debt owed to Chicago Pacific Founders into three series of non-voting preferred stock carrying cumulative dividend rates between 13.5% and 19.5%. The company simultaneously raised $10 million in new financing from CPF affiliates, with up to $60 million available in future tranches. Each $1 million invested includes warrants representing 0.66333% of outstanding common stock, creating meaningful dilution potential for existing shareholders.
The transactions addressed an immediate compliance crisis but concentrated control with CPF, which now holds enhanced governance rights including an additional board seat and protective provisions contingent on maintaining 40% common ownership. The related-party nature of these deals—CPF serving as both rescuer and largest creditor/shareholder—required special committee approval. Retail holders should monitor whether the high-cost preferred dividends (payable in cash or additional shares) strain operations, and whether CPF exercises its expanded influence to pursue strategies aligned with common shareholders or its own preferred position.
Section-by-Section Diff
Event · Item 1.01 — Entry into a Material Definitive Agreement
P3 Health Partners disclosed entry into a material definitive agreement on April 27, 2026.
Added in current filing · verify on EDGAR →
Item 1.01 Entry into a Material Definitive Agreement
The company filed an 8-K disclosing entry into a material definitive agreement on April 27, 2026. The filing body contains only the Item 1.01 header with no additional details about the nature, parties, terms, or business purpose of the agreement. Without substantive disclosure, investors cannot assess the materiality or impact of this transaction.
Event · Item 3.02 — Unregistered Sales of Equity Securities
P3 Health Partners disclosed an unregistered equity sale under Item 3.02.
The 8-K filing indicates Item 3.02 (Unregistered Sales of Equity Securities) was triggered, meaning the company issued equity securities without a public registration statement. The filing body provided does not contain the actual disclosure text describing the transaction details, such as the securities issued, consideration received, purchaser identity, or exemption relied upon.
Event · Item 5.03 — Amendments to Articles of Incorporation or Bylaws
P3 Health converted $252M debt to preferred stock and raised $10M to regain Nasdaq compliance; largest holder CPF gains board seat.
Added in current filing · verify on EDGAR →
on April 27, 2026, P3 Health Partners Inc. (the “Company”), and P3 Health Group, LLC, a wholly owned subsidiary of the Company (“P3HG”), entered into a Debt Exchange Agreement (the “Exchange Agreement”) with various affiliates of Chicago Pacific Founders, the largest stockholder and debtholder, directly or through affiliates, of the Company (“CPF,” and such affiliates, the “Holders”). Pursuant to the Exchange Agreement, approximately $252,479,967 of outstanding promissory notes, including principal, accrued interest, and back-end fees (collectively, the “Debt”), will be exchanged for preferred stock that is not convertible, does not have voting or preemptive rights, is not registered or listed, and has a stated value of $100 per share.
The company converted approximately $252.5 million of debt owed to Chicago Pacific Founders into non-convertible, non-voting preferred stock to regain compliance with Nasdaq's minimum $2.5 million stockholders' equity requirement. The debt included principal, accrued interest, and back-end fees. The preferred stock has a stated value of $100 per share and is redeemable by the company at any time.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 21, 2026 · How we verify